Song LH - Search Results

1

[Comparison of two quantitation methods of circulating tumor cells in patients with small cell lung cancer].

Guo XZ, Song LH, Feng B, Qiang L, Han CY, Xu DD. Guo XZ, et al. Among authors: song lh. Zhonghua Zhong Liu Za Zhi. 2013 May;35(5):347-50. doi: 10.3760/cma.j.issn.0253-3766.2013.05.006. Zhonghua Zhong Liu Za Zhi. 2013. PMID: 24054010 Chinese.

2

[Prognostic factors in patients with stage III and IV non-small cell lung cancer].

Song LH, Song XR, Liu MQ, Zhang XQ, Zheng L, Li XJ, Liu PX. Song LH, et al. Among authors: song xr. Zhonghua Zhong Liu Za Zhi. 2004 Jun;26(6):345-8. Zhonghua Zhong Liu Za Zhi. 2004. PMID: 15312344 Chinese.

3

[Prognostic factors in patients with small cell lung cancer].

Song LH, Song XR, Zhang XQ, Qi JL, Li XJ, Tian H, Bu B. Song LH, et al. Among authors: song xr. Zhonghua Zhong Liu Za Zhi. 2004 Jul;26(7):413-6. Zhonghua Zhong Liu Za Zhi. 2004. PMID: 15355646 Chinese.

4

[Clinical value of CEA and CYFRA21-1 as an assessment indicator of therapeutic efficacy in advanced non-small cell lung cancer patients].

Li L, Song LH, Ding SC, Zhang XJ, Qiang L, Han CY, Yuan XT, Xu DD. Li L, et al. Among authors: song lh. Zhonghua Zhong Liu Za Zhi. 2010 Nov;32(11):850-4. Zhonghua Zhong Liu Za Zhi. 2010. PMID: 21223692 Chinese.

5

A missense variant in EZH2 is associated with colorectal cancer risk in a Chinese population.

Li H, Chang C, Shang Y, Qiang L, Zhang B, Bu B, Ren G, Song L, Shang M, Yu J. Li H, et al. Oncotarget. 2017 Oct 16;8(55):94738-94742. doi: 10.18632/oncotarget.21888. eCollection 2017 Nov 7. Oncotarget. 2017. PMID: 29212262 Free PMC article.

6

Dynamic analysis of circulating tumor DNA to predict the prognosis and monitor the treatment response of patients with metastatic triple-negative breast cancer: A prospective study.

Chi Y, Su M, Zhou D, Zheng F, Zhang B, Qiang L, Ren G, Song L, Bu B, Fang S, Yu B, Zhou J, Yu J, Li H. Chi Y, et al. Elife. 2023 Nov 6;12:e90198. doi: 10.7554/eLife.90198. Elife. 2023. PMID: 37929934 Free PMC article.

7

Comparison of endocrine therapy and chemotherapy as different systemic treatment modes for metastatic luminal HER2-negative breast cancer patients -A retrospective study.

Liu Q, Qiu J, Lu Q, Ma Y, Fang S, Bu B, Song L. Liu Q, et al. Front Oncol. 2022 Jul 26;12:873570. doi: 10.3389/fonc.2022.873570. eCollection 2022. Front Oncol. 2022. PMID: 35957911 Free PMC article.

8

Durable Effect of Pyrotinib and Metronomic Vinorelbine in HER2-Positive Breast Cancer With Leptomeningeal Disease: A Case Report and Literature Review.

Chi Y, Shang M, Xu L, Gong H, Tao R, Song L, Zhang B, Yin S, Cong B, Li H. Chi Y, et al. Front Oncol. 2022 Feb 16;12:811919. doi: 10.3389/fonc.2022.811919. eCollection 2022. Front Oncol. 2022. PMID: 35251981 Free PMC article. Review.

9

Effectiveness and Safety of Pyrotinib-Based Therapy in the Treatment of HER2-Positive Breast Cancer Patients with Brain Metastases: A Multicenter Real-World Study.

Huang J, Sun S, Tan Q, Zheng F, Zhou D, Man X, Hu Y, Li W, Song L, Zhang B, Xu L, Wang X, Xie X, Li H. Huang J, et al. Clin Breast Cancer. 2024 Aug;24(6):e509-e518.e1. doi: 10.1016/j.clbc.2024.04.001. Epub 2024 Apr 6. Clin Breast Cancer. 2024. PMID: 38729821 Free article.

10

Impact of Empowerment Theory-Based Nursing Intervention on the Quality of Life and Negative Emotions of Patients Diagnosed with Brain Metastasis Post Breast Cancer Surgery [Letter].

Fang S, Shi W, Song L. Fang S, et al. J Multidiscip Healthc. 2024 Aug 12;17:3887-3888. doi: 10.2147/JMDH.S489036. eCollection 2024. J Multidiscip Healthc. 2024. PMID: 39155979 Free PMC article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

170 results

Search Page

Filters